ABOLOGIX
ABOLOGIX is developing best-in-class monoclonal antibodies by blocking the Junction Adhesion Molecule JAM-C and the extracellular matrix-related protein. The treatment is designed for patients that do not respond to traditional cancer therapies.
ABOLOGIX
Industry:
Biotechnology Medical Therapeutics
Founded:
2018-02-02
Address:
Plan-les-ouates, Geneve, Switzerland
Country:
Switzerland
Website Url:
http://www.abologix.com
Total Employee:
1+
Status:
Active
Contact:
+ 41 (022) 8801010
Email Addresses:
[email protected]
Total Funding:
160 K CHF
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Google GStatic Google Static Content Google Cloud Wix
Similar Organizations
Hookipa Pharma
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Theolytics
Theolytics is a pre-clinical stage biotechnology company developing next-generation oncolytic viral therapies.
Current Employees Featured
Founder
Investors List
Venture Kick
Venture Kick investment in Debt Financing - Abologix
Venture Kick
Venture Kick investment in Grant - Abologix
Official Site Inspections
http://www.abologix.com
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
